Dr Reddys Laboratories Ltd

Dr Reddy's Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Reddys Laboratories Ltd

₹ 1,246 0.03%
13 Dec 3:51 p.m.
drreddys.com BSE: 500124 NSE: DRREDDY
About

Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.

Key Points

Global Generics Segment (~83% of revenues in FY22)
Co. offers 400+ high-quality generic drugs, keeping costs reasonable by leveraging its integrated operations. The company benefits from its expertise in active ingredients, product development skills, a keen understanding of regulations and intellectual property rights & streamlined supply chain. [1]
Top revenue contributors of the segment are nervous system drugs (14%), gastrointestinal (13%) & anti-infective (10%) [2]
In FY22, co. filed 7 new ANDA’s with US FDA [3]

Website BSE NSE
  • Market Cap ₹ 1,04,001 Cr.
  • Current Price ₹ 1,246
  • High / Low ₹ 1,421 / 1,094
  • Stock P/E 19.5
  • Book Value ₹ 369
  • Dividend Yield 0.64 %
  • ROCE 26.5 %
  • ROE 21.4 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has delivered good profit growth of 24.4% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
5,787 5,338 5,475 5,233 6,332 6,790 6,315 6,758 6,903 7,237 7,114 7,696 8,038
4,427 4,123 5,024 4,292 4,433 4,851 4,781 4,696 4,894 5,214 5,283 5,566 5,962
Operating Profit 1,360 1,216 451 941 1,899 1,939 1,534 2,062 2,008 2,023 1,831 2,130 2,076
OPM % 24% 23% 8% 18% 30% 29% 24% 31% 29% 28% 26% 28% 26%
230 74 132 863 55 65 146 178 319 219 201 193 314
Interest 23 22 32 35 31 42 35 37 35 39 59 60 76
Depreciation 294 294 293 302 309 324 316 353 376 374 368 381 397
Profit before tax 1,272 974 259 1,468 1,614 1,638 1,329 1,850 1,917 1,829 1,605 1,883 1,917
Tax % 22% 27% 63% 19% 31% 24% 28% 24% 23% 24% 18% 26% 30%
996 709 97 1,189 1,114 1,244 960 1,405 1,482 1,381 1,310 1,392 1,342
EPS in Rs 11.97 8.52 1.17 14.29 13.39 14.94 11.53 16.87 17.77 16.56 15.70 16.69 15.05
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
11,833 13,415 15,023 15,568 14,196 14,281 15,448 17,517 19,048 21,545 24,670 28,011 30,085
9,164 10,164 11,515 11,983 11,724 11,930 12,270 15,040 15,173 17,778 18,200 20,078 22,024
Operating Profit 2,669 3,251 3,508 3,585 2,472 2,351 3,178 2,477 3,874 3,768 6,470 7,933 8,061
OPM % 23% 24% 23% 23% 17% 16% 21% 14% 20% 17% 26% 28% 27%
146 170 260 295 172 155 381 670 335 555 971 909 927
Interest 100 127 108 83 63 79 89 98 97 96 143 171 234
Depreciation 550 648 760 939 1,027 1,077 1,135 1,163 1,229 1,165 1,250 1,470 1,519
Profit before tax 2,165 2,646 2,900 2,859 1,554 1,350 2,336 1,886 2,884 3,061 6,048 7,201 7,234
Tax % 29% 26% 19% 26% 19% 32% 17% -7% 32% 29% 25% 23%
1,527 1,963 2,336 2,131 1,292 947 1,950 2,026 1,952 2,182 4,507 5,578 5,425
EPS in Rs 17.98 23.08 27.43 24.98 15.59 11.41 23.49 24.38 23.47 26.23 54.14 66.87 64.00
Dividend Payout % 17% 16% 15% 16% 26% 35% 17% 21% 21% 23% 15% 12%
Compounded Sales Growth
10 Years: 8%
5 Years: 13%
3 Years: 14%
TTM: 12%
Compounded Profit Growth
10 Years: 11%
5 Years: 24%
3 Years: 41%
TTM: 5%
Stock Price CAGR
10 Years: 7%
5 Years: 17%
3 Years: 10%
1 Year: 12%
Return on Equity
10 Years: 16%
5 Years: 17%
3 Years: 19%
Last Year: 21%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 85 85 85 85 83 83 83 83 83 83 83 83 83
Reserves 6,284 7,780 9,768 12,484 12,179 12,489 13,941 15,516 17,558 19,129 23,203 28,171 30,666
3,682 4,477 4,314 3,352 4,918 5,071 3,838 2,210 3,031 3,384 1,347 2,002 4,854
3,329 3,563 4,290 4,408 4,474 4,706 4,557 5,414 5,915 7,149 7,576 8,523 11,125
Total Liabilities 13,380 15,906 18,457 20,330 21,654 22,349 22,418 23,223 26,588 29,746 32,209 38,780 46,728
4,051 4,641 5,377 6,563 6,931 6,968 7,191 6,850 8,206 8,122 9,219 10,426 17,254
CWIP 565 639 529 772 3,324 3,470 2,934 1,535 1,565 1,293 1,030 1,419 1,852
Investments 197 1,067 2,248 3,833 2,110 2,298 2,587 2,678 2,212 2,616 4,986 4,930 3,663
8,567 9,559 10,303 9,162 9,290 9,612 9,707 12,160 14,605 17,715 16,974 22,004 23,960
Total Assets 13,380 15,906 18,457 20,330 21,654 22,349 22,418 23,223 26,588 29,746 32,209 38,780 46,728

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1,378 1,970 2,524 3,263 2,144 1,803 2,870 2,984 3,570 2,811 5,888 4,543
-1,437 -1,604 -2,370 -1,610 -1,890 -1,483 -769 -495 -2,255 -2,565 -4,109 -4,034
-157 -24 -433 -1,700 -369 -444 -2,133 -2,516 -30 -242 -2,686 -376
Net Cash Flow -216 342 -280 -47 -114 -124 -31 -27 1,286 3 -907 133

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 98 90 100 97 98 104 94 105 95 113 107 105
Inventory Days 229 271 248 248 282 263 273 230 273 250 232 283
Days Payable 102 100 84 88 104 121 111 100 109 111 108 116
Cash Conversion Cycle 225 261 264 257 275 246 256 235 259 252 231 271
Working Capital Days 79 88 79 87 98 104 93 93 103 108 102 137
ROCE % 25% 25% 22% 19% 9% 8% 13% 11% 16% 14% 27% 27%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
26.72% 26.72% 26.71% 26.71% 26.69% 26.69% 26.69% 26.66% 26.65% 26.65% 26.65% 26.64%
27.42% 25.16% 25.87% 26.26% 27.29% 27.25% 26.99% 28.19% 28.62% 29.13% 27.68% 27.53%
22.29% 24.78% 25.18% 24.69% 23.38% 23.05% 21.99% 21.04% 18.65% 18.31% 20.72% 21.48%
23.29% 23.07% 21.96% 22.06% 22.36% 22.78% 24.11% 23.93% 25.89% 25.73% 24.78% 24.20%
0.28% 0.28% 0.28% 0.27% 0.25% 0.22% 0.21% 0.18% 0.18% 0.17% 0.17% 0.16%
No. of Shareholders 2,42,3762,63,8032,55,3002,59,2712,46,7882,32,7152,46,7692,43,4452,57,7942,55,5002,67,6943,10,403

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls